These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25037468)

  • 1. Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.
    Yang Y; Ye Z; Zou Z; Xiao G; Luo G; Yang H
    Tumour Biol; 2014 Oct; 35(10):10333-40. PubMed ID: 25037468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
    Xu L; Lan H; Su Y; Li J; Wan J
    Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review.
    Lu XX; Zhu LQ; Pang F; Sun W; Ou C; Li Y; Cao J; Hu YL
    Genet Mol Res; 2014 Jul; 13(3):5182-9. PubMed ID: 25061743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance and potential drug target of RUNX3 in breast cancer.
    Yu YY; Chen C; Kong FF; Zhang W
    Drug Des Devel Ther; 2014; 8():2423-30. PubMed ID: 25525332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of tumour suppressor genes
    El-Bendary M; Nour D; Arafa M; Neamatallah M
    Br J Biomed Sci; 2020 Jan; 77(1):35-40. PubMed ID: 31790342
    [No Abstract]   [Full Text] [Related]  

  • 6. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
    Zhang X; He H; Zhang X; Guo W; Wang Y
    Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.
    Zang JJ; Xie F; Xu JF; Qin YY; Shen RX; Yang JM; He J
    World J Gastroenterol; 2011 Jul; 17(25):3043-8. PubMed ID: 21799651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis.
    Lu DG; Ma YM; Zhu AJ; Han YW
    Oncotarget; 2017 Mar; 8(13):22166-22174. PubMed ID: 27825140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 promoter methylation correlation with pathogenesis of hepatocellular carcinoma in Asians.
    Lu W; Liu Y; Liu LL; Zhuang PH
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis.
    Mu WP; Wang J; Niu Q; Shi N; Lian HF
    Onco Targets Ther; 2014; 7():1237-45. PubMed ID: 25053885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of RUNX3 protein in hepatic cell carcinoma and its clinicopathological implications].
    Lu YH; Zheng RD; Chen J; Chen BF; Li JG; Lin ZC
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):329-32. PubMed ID: 21354923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation analysis of p16, SLIT2, SCARA5, and Runx3 genes in hepatocellular carcinoma.
    Sun G; Zhang C; Feng M; Liu W; Xie H; Qin Q; Zhao E; Wan L
    Medicine (Baltimore); 2017 Oct; 96(41):e8279. PubMed ID: 29019900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis.
    Wang Y; Qin X; Wu J; Qi B; Tao Y; Wang W; Liu F; Li H; Zhao B
    PLoS One; 2014; 9(9):e107598. PubMed ID: 25229459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
    Li Y; Cai Y; Chen H; Mao L
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S486-S489. PubMed ID: 29970711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.
    Xiao WH; Liu WW
    World J Gastroenterol; 2004 Feb; 10(3):376-80. PubMed ID: 14760761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
    Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
    Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Oxidative Stress and RUNX3 Hypermethylation in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma (HCC) and Induction of RUNX3 Hypermethylation by Reactive Oxygen Species in HCC Cells.
    Poungpairoj P; Whongsiri P; Suwannasin S; Khlaiphuengsin A; Tangkijvanich P; Boonla C
    Asian Pac J Cancer Prev; 2015; 16(13):5343-8. PubMed ID: 26225676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma.
    Shiraha H; Nishina S; Yamamoto K
    J Cell Biochem; 2011 Mar; 112(3):745-9. PubMed ID: 21328447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance].
    Xiao WH; Liu WW
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):227-30. PubMed ID: 15099475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.